1. Suzuki O. Octacalcium phosphate: osteoconductivity and crystal chemistry. Acta Biomater. 2010;6(9):3379-3387.
2. Giannoudis PV, Dinopoulos H, Tsiridis E. Bone substitutes: an update. Injury. 2005;36 Suppl 3:S20-27.
3. McAllister BS, Haghighat K. Bone augmentation techniques. J Periodontol. 2007;78(3):377-396.
4. Campana V, Milano G, Pagano E, et al. Bone substitutes in orthopaedic surgery: from basic science to clinical practice. J Mater Sci Mater Med. 2014;25(10):2445-2461.
5. Schmidmaier G, Herrmann S, Green J, et al. Quantitative assessment of growth factors in reaming aspirate, iliac crest, and platelet preparation. Bone. 2006;39(5):1156-1163.
6. Klinge B, Alberius P, Isaksson S, et al. Osseous response to implanted natural bone mineral and synthetic hydroxylapatite ceramic in the repair of experimental skull bone defects. J Oral Maxillofac Surg. 1992;50(3):241-249.
7. Bashoor-Zadeh M, Baroud G, Bohner M. Simulation of the in vivo resorption rate of β- tricalcium phosphate bone graft substitutes implanted in a sheep model. Biomaterials. 2011;32(27):6362-6373.
8. Galea LG, Bohner M, Lemaître J, et al. Bone substitute: transforming beta-tricalcium phosphate porous scaffolds into monetite. Biomaterials. 2008;29(24-25):3400-3407.
9. Suzuki O, Kamakura S, Katagiri T, et al. Bone formation enhanced by implanted octacalcium phosphate involving conversion into Ca-deficient hydroxyapatite. Biomaterials. 2006;27(13):2671-2681.
10. Suzuki O, Nakamura M, Miyasaka Y, et al. Bone formation on synthetic precursors of hydroxyapatite. Tohoku J Exp Med. 1991;164(1):37-50.
11. LeGeros RZ, Daculsi G, Orly I, et al. Solution-mediated transformation of octacalcium phosphate (OCP) to apatite. Scanning Microsc. 1989;3(1):129-137; discussion 137-138.
12. Brown WE, Smith JP, Lehr JR, et al. Octacalcium Phosphate and Hydroxyapatite: Crystallographic and Chemical Relations between Octacalcium Phosphate and Hydroxyapatite. Nature. 1962;196(4859):1050-1055.
13. Suzuki O, Shiwaku Y, Hamai R. Octacalcium phosphate bone substitute materials: Comparison between properties of biomaterials and other calcium phosphate materials. Dent Mater J. 2020;39(2):187-199.
14. Imaizumi H, Sakurai M, Kashimoto O, et al. Comparative study on osteoconductivity by synthetic octacalcium phosphate and sintered hydroxyapatite in rabbit bone marrow. Calcif Tissue Int. 2006;78(1):45-54.
15. Miyatake N, Kishimoto KN, Anada T, et al. Effect of partial hydrolysis of octacalcium phosphate on its osteoconductive characteristics. Biomaterials. 2009;30(6):1005-1014.
16. Suzuki O, Imaizumi H, Kamakura S, et al. Bone regeneration by synthetic octacalcium phosphate and its role in biological mineralization. Curr Med Chem. 2008;15(3):305-313.
17. Suzuki K, Honda Y, Anada T, et al. Stimulatory capacity of an octacalcium phosphate/gelatin composite on bone regeneration. Phosphorus Research Bulletin. 2012;26:53-58.
18. Suzuki K, Anada T, Miyazaki T, et al. Effect of addition of hyaluronic acids on the osteoconductivity and biodegradability of synthetic octacalcium phosphate. Acta Biomaterialia. 2014;10(1):531-543.
19. Saito K, Anada T, Shiwaku Y, et al. Dose-dependent enhancement of octacalcium phosphate biodegradation with a gelatin matrix during bone regeneration in a rabbit tibial defect model. RSC Adv. 2016;6(69):64165-64174.
20. Fuji T, Anada T, Honda Y, et al. Octacalcium phosphate-precipitated alginate scaffold for bone regeneration. Tissue Eng Part A. 2009;15(11):3525-3535.
21. Chiba S, Anada T, Suzuki K, et al. Effect of resorption rate and osteoconductivity of biodegradable calcium phosphate materials on the acquisition of natural bone strength in the repaired bone. J Biomed Mater Res. 2016;104(11):2833-2842.
22. Baba K, Shiwaku Y, Hamai R, et al. Chemical Stability-Sensitive Osteoconductive Performance of Octacalcium Phosphate Bone Substitute in an Ovariectomized Rat Tibia Defect. Published online 2020:15.
23. Handa T, Anada T, Honda Y, et al. The effect of an octacalcium phosphate co-precipitated gelatin composite on the repair of critical-sized rat calvarial defects. Acta Biomater. 2012;8(3):1190-1200.
24. Kurobane T, Shiwaku Y, Anada T, et al. Angiogenesis involvement by octacalcium phosphate-gelatin composite-driven bone regeneration in rat calvaria critical-sized defect. Acta Biomaterialia. 2019;88:514-526.
25. Ishiko-Uzuka R, Anada T, Kobayashi K, et al. Oriented bone regenerative capacity of octacalcium phosphate/gelatin composites obtained through two-step crystal preparation method. J Biomed Mater Res. 2017;105(5):1029-1039.
26. Drosse I, Volkmer E, Seitz S, et al. Validation of a femoral critical size defect model for orthotopic evaluation of bone healing: a biomechanical, veterinary and trauma surgical perspective. Tissue Eng Part C Methods. 2008;14(1):79-88.
27. Nakashima T, Hayashi M, Takayanagi H. New insights into osteoclastogenic signaling mechanisms. Trends Endocrinol Metab. 2012;23(11):582-590.
28. Burstone MS. Histochemical demonstration of acid phosphatase activity in osteoclasts. J Histochem Cytochem. 1959;7(1):39-41.
29. Hayman AR, Bune AJ, Bradley JR, et al. Osteoclastic tartrate-resistant acid phosphatase (Acp 5): its localization to dendritic cells and diverse murine tissues. J Histochem Cytochem. 2000;48(2):219-228.
30. Groot CG, Danes JK, Blok J, et al. Light and electron microscopic demonstration of osteocalcin antigenicity in embryonic and adult rat bone. Bone. 1986;7(5):379-385.
31. Nishimoto SK, Price PA. Proof that the gamma-carboxyglutamic acid-containing bone protein is synthesized in calf bone. Comparative synthesis rate and effect of coumadin on synthesis. J Biol Chem. 1979;254(2):437-441.
32. Matthews BG, Grcevic D, Wang L, et al. Analysis of αSMA-labeled progenitor cell commitment identifies notch signaling as an important pathway in fracture healing. J Bone Miner Res. 2014;29(5):1283-1294.
33. Mori Y, Adams D, Hagiwara Y, et al. Identification of a progenitor cell population destined to form fracture fibrocartilage callus in Dickkopf-related protein 3-green fluorescent protein reporter mice. J Bone Miner Metab. 2016;34(6):606-614.
34. Leiblein M, Koch E, Winkenbach A, et al. Size matters: Effect of granule size of the bone graft substitute (Herafill®) on bone healing using Masquelet’s induced membrane in a critical size defect model in the rat’s femur. J Biomed Mater Res B Appl Biomater. 2020;108(4):1469-1482.
35. Nau C, Simon S, Schaible A, et al. Influence of the induced membrane filled with syngeneic bone and regenerative cells on bone healing in a critical size defect model of the rat’s femur. Injury. 2018;49(10):1721-1731.
36. Lu JX, Flautre B, Anselme K, et al. Role of interconnections in porous bioceramics on bone recolonization in vitro and in vivo. J Mater Sci Mater Med. 1999;10(2):111-120.
37. Hirayama B, Anada T, Shiwaku Y, et al. Immune cell response and subsequent bone formation induced by implantation of octacalcium phosphate in a rat tibia defect. RSC Adv. 2016;6(62):57475-57484.
38. Anada T, Kumagai T, Honda Y, et al. Dose-dependent osteogenic effect of octacalcium phosphate on mouse bone marrow stromal cells. Tissue Eng Part A. 2008;14(6):965-978.
39. Kikawa T, Kashimoto O, Imaizumi H, et al. Intramembranous bone tissue response to biodegradable octacalcium phosphate implant. Acta Biomater. 2009;5(5):1756-1766.
40. Takami M, Mochizuki A, Yamada A, et al. Osteoclast differentiation induced by synthetic octacalcium phosphate through receptor activator of NF-kappaB ligand expression in osteoblasts. Tissue Eng Part A. 2009;15(12):3991-4000.
41. Sasano Y, Kamakura S, Homma H, et al. Implanted octacalcium phosphate (OCP) stimulates osteogenesis by osteoblastic cells and/or committed osteoprogenitors in rat calvarial periosteum. Anat Rec. 1999;256(1):1-6.
42. Kamakura S, Sasano Y, Homma-Ohki H, et al. Multinucleated giant cells recruited by implantation of octacalcium phosphate (OCP) in rat bone marrow share ultrastructural characteristics with osteoclasts. J Electron Microsc (Tokyo). 1997;46(5):397-403.
43. Matsuo K, Irie N. Osteoclast-osteoblast communication. Arch Biochem Biophys. 2008;473(2):201-209.